Referred to as -X modifiers, they are designed to define specific subsets of -59 modifier
Are Insurance Companies’ Medication Directives Fiscally, Medically Questionable?
A reader questions whether insurers’ practice of promoting medications has undermined physicians’ ability to provide quality patient care
Atypical Fractures Associated with Bisphosphonates
Plus, FX006, odanacatib and other rheumatology drug news, safety updates
The Rheumatology Podcast Informs, Entertains
Rheumatologist-narrated podcasts about clinical, topical issues in rheumatology help colleagues stay connected to specialty
Ethics Forum: Electronic Health Records Raise Concerns about Physician-Patient Relationship
Health information technology may distract physicians during exam room visits with patients
Decernotinib, Subcutaneous Methotrexate Drug Updates, Trials, Approvals
Plus, rheumatology drug news, safety updates
Diagnosis, Treatment for Patient with Psoriasis, Fever, Bloating, and Rash
A 65-year-old man presents with symptoms of erythrodermic psoriasis flare
Accelerating Medicines Partnership Targets Therapies for Rheumatoid Arthritis, Systemic Lupus Erythematosus
Research collaboration among scientists, pharmaceutical companies, nonprofits promotes precompetitive sharing of data collection, analyses
Treatment, Management Options for Difficult-to-Control Gout
Patient education is key to medication compliance, battling gouty flares
ANCA-Associated Vasculitis in Systemic Sclerosis
A case report
- « Previous Page
- 1
- …
- 6
- 7
- 8
- 9
- 10
- …
- 21
- Next Page »